Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2016 September;58(3) > Panminerva Medica 2016 September;58(3):242-3

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   

Panminerva Medica 2016 September;58(3):242-3

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Changes in antithrombotic therapy after a cerebrovascular or coronary ischemic event in the WARfarin and coronary STENTing (WAR-STENT) registry

Andrea RUBBOLI 1, Cataldo PALMIERI 2, Giancarlo PIOVACCARI 3, Giuseppe DI PASQUALE 4, Carlo BRIGUORI 5, Massimo MARGHERI 6 , for the WARfarin and coronary STENTing (WAR-STENT) Study Group

1 Division of Cardiology, Laboratory of Interventional Cardiology, Ospedale Maggiore, Bologna, Italy; 2 Division of Cardiology, Ospedale del Cuore “G. Pasquinucci”, Massa, Italy; 3 Division of Cardiology, Ospedale degli Infermi, Rimini, Italy; 4 Division of Cardiology, Ospedale Maggiore, Bologna, Italy; 5 Department of Cardiology, Clinica Mediterranea, Napoli, Italy; 6 Department of Cardiology, Ospedale S. Maria delle Croci, Ravenna, Italy


PDF


top of page